↓ Skip to main content

Oncotarget

Article Metrics

Molecular pathways and therapeutic targets in lung cancer

Overview of attention for article published in Oncotarget, April 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
5 tweeters
patent
3 patents

Citations

dimensions_citation
123 Dimensions

Readers on

mendeley
199 Mendeley
Title
Molecular pathways and therapeutic targets in lung cancer
Published in
Oncotarget, April 2014
DOI 10.18632/oncotarget.1891
Pubmed ID
Authors

Emma Shtivelman, Thomas Hensing, George R. Simon, Phillip A. Dennis, Gregory A. Otterson, Raphael Bueno, Ravi Salgia

Abstract

Lung cancer is still the leading cause of cancer death worldwide. Both histologically and molecularly lung cancer is heterogeneous. This review summarizes the current knowledge of the pathways involved in the various types of lung cancer with an emphasis on the clinical implications of the increasing number of actionable molecular targets. It describes the major pathways and molecular alterations implicated in the development and progression of non-small cell lung cancer (adenocarcinoma and squamous cancer), and of small cell carcinoma, emphasizing the molecular alterations comprising the specific blueprints in each group. The approved and investigational targeted therapies as well as the immune therapies, and clinical trials exploring the variety of targeted approaches to treatment of lung cancer are the main focus of this review.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 199 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 3 2%
Spain 1 <1%
Japan 1 <1%
Unknown 194 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 42 21%
Student > Master 38 19%
Researcher 26 13%
Student > Ph. D. Student 25 13%
Other 12 6%
Other 34 17%
Unknown 22 11%
Readers by discipline Count As %
Medicine and Dentistry 48 24%
Biochemistry, Genetics and Molecular Biology 46 23%
Agricultural and Biological Sciences 44 22%
Pharmacology, Toxicology and Pharmaceutical Science 17 9%
Immunology and Microbiology 5 3%
Other 10 5%
Unknown 29 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 January 2020.
All research outputs
#3,321,059
of 16,797,794 outputs
Outputs from Oncotarget
#1,311
of 13,095 outputs
Outputs of similar age
#39,430
of 195,763 outputs
Outputs of similar age from Oncotarget
#7
of 69 outputs
Altmetric has tracked 16,797,794 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,095 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,763 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.